iPath Pure Beta S&P GSCI-Weighted ETN
SBV
SBV was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $0 invested in iPath Pure Beta S&P GSCI-Weighted ETN in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less capital invested
Capital invested by funds: $236K → $0 (-$236K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$225K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
SBV Hedge Fund Activity: Q4 2016 in Review
1 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta S&P GSCI-Weighted ETN (SBV) for Q4 2016, worth a combined $0 — down 100% from $236K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SBV and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $225K sold.
- 1 institutional investor held iPath Pure Beta S&P GSCI-Weighted ETN (SBV) as of Q4 2016, down from 3 in Q3 2016.
- Funds reported $0 of iPath Pure Beta S&P GSCI-Weighted ETN stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta S&P GSCI-Weighted ETN positions in Q4 2016 and 2 closed out, a net change of -2 holders.
- The largest iPath Pure Beta S&P GSCI-Weighted ETN seller in Q4 2016 was Jane Street, an estimated $225K sold.
Based on aggregated 13F filings for Q4 2016.